2026 NPPES data Cardiovascular Disease Physician NPI 1346206174 M.D. FACC
Verify on CMS →

SUBROTO GANGOPADHYAY, M.D. FACC

Cardiovascular Disease Physician in SUGAR LAND, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 526 beneficiaries · Cardiovascular Disease Physician avg: 3K
Generic prescribing
88%
generic claims · 12% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
70.311/100
▼ 13 pts below national avg 83.1 · [object Object]
Industry payments
$546.64
13 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

SUBROTO GANGOPADHYAY, M.D. FACC reported a CMS MIPS final score of 70.311/100 — below the 83.1 national average — and filed 2,963 Medicare Part D claims in 2023.

70.311/100
MIPS score · -13 vs avg
3K
Part D claims, 2023
88%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

SUBROTO GANGOPADHYAY, M.D. FACC's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

70 8th percentile higher than 8% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

SUBROTO GANGOPADHYAY, M.D. FACC practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about SUBROTO GANGOPADHYAY, M.D. FACC?

Below national average

NPI registry status

Active

Issued 04/21/2006

NPI 1346206174

Primary specialty

Cardiovascular Disease Physician

Mid-sized

24,795 US NPIs in this specialty

Medicare Part D claims

2,963 2% vs specialty avg

2023 prescription claims

Specialty avg: 3,033

MIPS final score

70.311/100 12.788999999999987% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in Texas

How Cardiovascular Disease Physician compares to other specialties among Texas providers

Texas providers

Cardiovascular Disease Physician share within Texas

1. Cardiovascular Disease Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Cardiovascular Disease Physician share within Texas

Medicare quality performance — MIPS

SUBROTO GANGOPADHYAY, M.D. FACC's 2023 MIPS final score plotted against the Cardiovascular Disease Physician national average

Below national average
MIPS Final Score
70.311/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Cardiovascular Disease Physician) — 70.311/100 vs national avg 83.1

0%100%National avg83%70.3%
MIPS final score (Cardiovascular Disease Physician) — 70.311/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SUBROTO GANGOPADHYAY, M.D. FACC appears in the CMS NPPES registry as a Cardiovascular Disease Physician provider holding M.D. FACC credentials at 17510 W GRAND PKWY S, SUGAR LAND, TX, 77479, with a listed phone of (281) 565-6999. NPI 1346206174 was issued on 04/21/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GANGOPADHYAY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,963 prescription claims written by this provider, covering 526 Medicare beneficiaries and totaling roughly $483K in drug spend, split 12% brand-name and 88% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 70.311/100 for the 2023 performance year (Quality 64.1543, Cost 48.831), compared with the national average of 83.1.

Cardiovascular Disease Physician is a mid-sized specialty nationwide, with 24,795 enrolled providers across 54 states and an average of 3,033 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

17510 W GRAND PKWY S
SUGAR LAND, TX 77479

Provider Details

NPI 1346206174
Specialty Cardiovascular Disease Physician
Credentials M.D. FACC
Gender Male
NPI Issued 04/21/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

70.311
Final Score
Avg: 83.1
64.1543
Quality
48.831
Cost

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SUBROTO GANGOPADHYAY, M.D. FACC. Source: openpaymentsdata.cms.gov.

Total received

$547

Largest payer

Lexicon Pharmaceuticals, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to SUBROTO GANGOPADHYAY, M.D. FACC. To verify SUBROTO GANGOPADHYAY, M.D. FACC's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

SUBROTO GANGOPADHYAY, M.D. FACC — brand share 12.0%
Specialty average (est.)

12% brand-name claims vs 88% generic, on 2,963 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,963
Total Claims
$483K
Total Drug Cost
526
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
8,307
Total Day Supply
248,063
Brand vs Generic
12% brand / 88% generic
Brand Drug Cost
$396K
Generic Drug Cost
$87K

Patient Demographics

Average Patient Age
75.6 years
Avg HCC Risk Score
1.66
Gender Split
49% female / 51% male
Age Distribution
<65: 22, 65-74: 215, 75-84: 220, 85+: 69

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What SUBROTO GANGOPADHYAY, M.D. FACC prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Metoprolol Succinate
333
Atorvastatin Calcium
247
Amlodipine Besylate
190
Carvedilol
167
Rosuvastatin Calcium
142
Losartan Potassium
135
Eliquis
Apixaban
126
Clopidogrel
Clopidogrel Bisulfate
122
Furosemide
118
Lisinopril
91

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Cardiovascular Disease Physician Overview

How SUBROTO GANGOPADHYAY, M.D. FACC fits within the Cardiovascular Disease Physician landscape nationally.

24,795
Cardiovascular Disease Physician Providers in US
54
States with Cardiovascular Disease Physician
3,033
Avg Claims per Provider

SUBROTO GANGOPADHYAY, M.D. FACC's 2,963 claims are below the specialty average of 3,033.

Nearby Cardiovascular Disease Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as GANGOPADHYAY.

Compare Cardiovascular Disease Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SUBROTO GANGOPADHYAY, M.D. FACC's specialty?
SUBROTO GANGOPADHYAY, M.D. FACC specializes in Cardiovascular Disease Physician and practices in SUGAR LAND, Texas. Credentials: M.D. FACC.
How much does SUBROTO GANGOPADHYAY, M.D. FACC prescribe under Medicare Part D?
In 2023, SUBROTO GANGOPADHYAY, M.D. FACC wrote 2,963 Medicare Part D claims totaling $483K in drug costs for 526 beneficiaries.
What is SUBROTO GANGOPADHYAY, M.D. FACC's Medicare quality score?
SUBROTO GANGOPADHYAY, M.D. FACC has a CMS MIPS Final Score of 70.311/100 (Quality: 64.1543, Cost: 48.831). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is SUBROTO GANGOPADHYAY, M.D. FACC located?
SUBROTO GANGOPADHYAY, M.D. FACC is located at 17510 W GRAND PKWY S, SUGAR LAND, TX, 77479. Phone: (281) 565-6999.
What is SUBROTO GANGOPADHYAY, M.D. FACC's NPI number?
SUBROTO GANGOPADHYAY, M.D. FACC's National Provider Identifier (NPI) is 1346206174, issued on 04/21/2006.
Does SUBROTO GANGOPADHYAY, M.D. FACC prescribe more brand-name or generic drugs?
SUBROTO GANGOPADHYAY, M.D. FACC's prescribing is 12% brand-name and 88% generic drugs by claim count, with $396K in brand drug costs.
How many Cardiovascular Disease Physician providers are there in the US?
There are 24,795 Cardiovascular Disease Physician providers across 54 states in the US. The average Cardiovascular Disease Physician provider writes 3,033 Medicare Part D claims per year.
What drugs does SUBROTO GANGOPADHYAY, M.D. FACC prescribe most often?
Based on 2023 Medicare Part D data, SUBROTO GANGOPADHYAY, M.D. FACC's most frequently prescribed drugs include Metoprolol Succinate, Atorvastatin Calcium, Amlodipine Besylate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SUBROTO GANGOPADHYAY, M.D. FACC accept Medicare?
SUBROTO GANGOPADHYAY, M.D. FACC appears in CMS Medicare data with 2,963 Part D claims and 526 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SUBROTO GANGOPADHYAY, M.D. FACC's credentials?
SUBROTO GANGOPADHYAY, M.D. FACC's NPI is 1346206174 with credentials M.D. FACC. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology